BOSTON, Nov. 27, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: RNAZ), the RNA Oncology Companyâ„¢ committed to more effectively treating cancer using RNA therapeutics, today announced that it has entered into a ...